Pre-Conference Workshop: Clinical Trials: Increasing and Improving Design, Representation, and Access

Thursday, November 14, 2024

9:00 AM – 11:30 AM CT

Location: San Antonio 1

CE: 2.50 credits/hours

Speaker(s)

Erin M. Pierce, MSN, APRN, FNP-C

Ochsner MD Anderson Cancer Center
Metairie, Louisiana, United States
Theresa W. Gillespie, PhD, MA, RN, FAAN (she/her/hers)

Professor & Associate Center Director, Cancer Health Equity & Community Engagement
Emory University, Winship Cancer Institute
Decatur, Georgia, United States

Disclosures:

Erin Pierce has served on advisory boards for Eisai, Exelixis, Johnson & Johnson, and Seagen; on speakers bureaus for Astellas, Eisai, Exelixis, Johnson & Johnson, Pfizer, Sanofi, Seagen, and Merck; and as a consultant for Exelixis, Johnson & Johnson, and Merck.
Theresa Gillespie has no relevant financial relationships to disclose.

Learning Objectives:

Describe the importance of diversity in clinical trials and key barriers to representative enrollment
Discuss the evidence related to strategies to improve clinical trial representation and access
Apply evidence and data presented to the participant's own clinical setting and population to enhance diversity of trial enrollment
Illustrate how advanced practitioners can act as change agents to promote better representation on clinical trials